Join ISPOR and the Innovation and Value Initiative (IVI) on October 23, 2020 for the fourth instalment of a free 5-part webinar series dedicated to the challenges of the HEOR community during COVID-19.
COVID-19 has unmasked the critical need for public health expertise and investment. How can the risks and benefits of public health policy interventions be best addressed by VA/HTA? How can interactions between health and other sectors in our economy be modelled in a way that is useful and informative? What roles do the public and private sector play in public health infrastructure and interventions? How can VA/HTA help frame the policy implications for public health investment? Topics of discussion include:
- Incorporating policy and non-pharmaceutical interventions in the VA/HTA
- How VA/HTA accounts for effect of new treatments on non-COVID related care
- Setting priorities in public health infrastructure investment
- Evaluating and prioritize policy interventions
- The roles of US and global government agencies in public health investment
Murray Ross, PhD, Vice President, Kaiser Foundation Health Plan, Inc., Oakland, CA, USA
Yannis Natsis, Policy Manager Universal Access and Affordable Medicines, European Public Health Alliance (EPHA), Brussels, Belgium
Reed Tuckson, MD, FACP, Managing Director, Tuckson Health Connections, LLC, Washington DC, USA
Marcus Keogh-Brown, PhD, Associate Professor, London School of Hygiene & Tropical Medicine, London, England, UK
Henning Tarp Jensen, PhD, Associate Professor of Macroeconomics and Simulation Modeling, London School of Hygiene & Tropical Medicine, London, England, UK
Penny Mohr, MA, Senior Advisor, Emerging Technology and Delivery System Innovation Research Initiatives, PCORI, Washington DC, USA
Register here today!